Skip to content
Catalyst

PapersPMID:19937427

Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.

Osteoporosis international2010The record ↗

  1. Finding, very limited evidencelowersSerum undercarboxylated osteocalcin concentration

What moved

1 findingHow to read these marks →
  • “Serum levels of cOC increased and ucOC decreased in the treatment versus the placebo group (p < 0.001).”
    Study
    RCT
    Duration
    12 months
    Dose studied
    360 microg MK-7 in the form of Natto capsules, 12 months (dosing frequency not stated in the abstract); placebo was identical-looking olive-oil capsules
    Population
    Healthy Norwegian women aged 50-60 years, 1-5 years after menopause

Study record

Design
randomised controlled trial
Species
human
Population
healthy postmenopausal Norwegian women between 50 and 60 years, 1-5 years after menopause
Participants
334
Comparator
placebo
Duration
365 days
Endpoints measured
6